LianBio Statistics
Total Valuation
LianBio has a market cap or net worth of 31.81 million. The enterprise value is -183.79 million.
| Market Cap | 31.81M |
| Enterprise Value | -183.79M |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LianBio has 108.17 million shares outstanding.
| Shares Outstanding | 108.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 1.32% |
| Owned by Institutions (%) | 0.15% |
| Float | 101.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.09 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.19 |
Financial Position
The company has a current ratio of 10.06, with a Debt / Equity ratio of 1.20.
| Current Ratio | 10.06 |
| Quick Ratio | 9.91 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.42% and return on invested capital (ROIC) is -24.20%.
| Return on Equity (ROE) | -32.42% |
| Return on Assets (ROA) | -21.67% |
| Return on Capital (ROIC) | -24.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -539,761 |
| Employee Count | 163 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.02% in the last 52 weeks. The beta is 0.00, so LianBio's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -80.02% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 40.29 |
| Average Volume (20 Days) | 29,884 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -106.56M |
| Pretax Income | -87.11M |
| Net Income | -87.98M |
| EBITDA | -105.26M |
| EBIT | -106.56M |
| Earnings Per Share (EPS) | -0.82 |
Balance Sheet
The company has 252.22 million in cash and 2.84 million in debt, giving a net cash position of 249.38 million or 2.31 per share.
| Cash & Cash Equivalents | 252.22M |
| Total Debt | 2.84M |
| Net Cash | 249.38M |
| Net Cash Per Share | 2.31 |
| Equity (Book Value) | 236.11M |
| Book Value Per Share | 1.89 |
| Working Capital | 232.18M |
Cash Flow
In the last 12 months, operating cash flow was -83.53 million and capital expenditures -464,000, giving a free cash flow of -83.99 million.
| Operating Cash Flow | -83.53M |
| Capital Expenditures | -464,000 |
| Free Cash Flow | -83.99M |
| FCF Per Share | -0.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LianBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.54% |
| Shareholder Yield | -7.54% |
| Earnings Yield | -278.53% |
| FCF Yield | -264.03% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |